Natural Molecule Could Improve Parkinson's
A natural molecule shows benefit in preliminary clinical trial for Parkinson’s Disease
According to many, the lack of dopamine in the brain is thought to be the cause of Parkinson’s disease. Current treatments for Parkinson’s include replacing dopamine within the brain and medications that are designed to slow the progression of the disease. In this study, researchers found that the natural molecule, n-acetylcysteine (NAC), with it’s strong antioxidant effects, could potentially benefit Parkinson’s disease management for patients. “This study reveals a potentially new avenue for managing Parkinson’s patients and shows that n-acetylcysteine may have a unique physiological effect that alters the disease process and enables dopamine neurons to recover some function,” said senior author on the paper Daniel Monti, MD, MBA, director of the Myrna Brind Center of Integrative Medicine and the Brind-Marcus Center of Integrative Medicine at Thomas Jefferson University. To read more, click here.
GOODMAN Oral Board Preparation Course Tumor
Nov. 1-3, 2017; Glendale, Ariz.
Computer Assisted Radiology and Surgery 31st International Congress and Exhibition
June 20-24, 2017; Barcelona, Spain
2017 New England Neurological Society Annual Meeting
June 22-24, 2017; Chatham, Mass.
June 29-30, 2017; Germany
2nd International Conference on Spine and Spinal Disorders
July 24-26, 2017; Rome, Italy